Market Need

The global medical robotic systems market was worth $5.48 billion in 2011 and is expected to reach $13.6 billion in 2018, growing at a compounded annual growth rate of 12.6% from 2012 [1].

XACT’s technology can apply to a wide range of applications, procedures and target organs using different imaging systems within the image guided and robot-assisted surgery market. After careful consideration the Company decided to initially address the growing need for novel technology to assist in CT guided procedures.

Biopsies, ablations and other interventional procedures are currently performed manually under CT guidance by interventional radiologists.

The XACT™ system will bring many benefits to the current standard of care including:

  • Lessen the exposure of interventional radiologists and patients to large radiation doses
  • Easily target and reach small lesions
  • Simple performance of complex angulation 3D needle trajectories
  • Ongoing path correction to maintain planned trajectory without needle re-insertion/s
  • Active compensation for target movement resulting from breathing or patient movement
  • Predictable procedure duration to prevent clogging up costly CT time
  • Significant decrease in the learning curve for interventional radiologists

The market is in need of a safe, accurate, and predictable method for performing interventional CT-guided procedures, which will allow more interventional radiologists to safely and effectively treat more patients in need.

Need more info?
Send us a message
© XACT Robotics™ 2018. All Rights Reserved. | Website by Volle'